For over 11 years, PlatformQ Health has been improving health outcomes through trusted digital education solutions for patients, caregivers and providers. Our therapeutically-aligned learning channels, extensive partner network, trusted database and best-in-class outcomes approach are proven to drive meaningful learning experiences.

With 5 years+ of accredited CME education in Mood Disorders with our partner DBSA, MDD has been a special focus. Our learning formats range between provider focused accredited to our “tethered” format that includes both an accredited component as well as a patient education component. Our 2022 initiative in planning consists of thematic topics in an accredited series, including treatment resistance, emerging therapies, clinical trials, and more.

Our partner, DBSA is the leading national organization focusing on the 2 most prevalent mental health conditions, depression and bipolar disorder, which affect more than 21 million Americans, account for 90% of the nation’s suicides every year, and cost $23 billion in lost workdays and other workplace losses.

Outcomes from our recent MDD tethered program

Educational Impact at 2-months post:

• 89% of clinicians reported positive impact on patient experience or outcome 
• 92% of clinicians reported positive impact on clinical practice change
• Greatest reported practice impact categories were confidence in managing patients with MDD (44%), ability to identify barriers to achieving patient-desired outcomes in patients with MDD (38%), and ability to assess the safety, efficacy and tolerability of new and evolving treatment options (36%).

To view more, here is a link to our current on-demand MDD program:

• Session 1
• Session 2

To view more, here is a link to our current on-demand Postpartum Depression program.

We are currently seeking funding for this year’s initiative. To learn more about this year’s program details, email Maria Arnone, Vice President EDU Digital Education, marnone@platformq.com.